Literature DB >> 17141078

Considerations in incorporating office-based ultrasound of the head and neck.

Nadeem A Akbar1, Donald L Bodenner, Lawrence T Kim, James Y Suen, Mimi S Kokoska.   

Abstract

OBJECTIVE: The purpose of this study was to determine the cost considerations and strategies for incorporating ultrasound (US) in a head and neck practice. STUDY DESIGN AND
SETTING: A retrospective chart review of office-based US procedures from 2001 to 2005 was completed at our academic medical center. Billing and coding for US and US guided fine needle aspiration (USFNA) were examined.
RESULTS: The appropriate CPT codes are 76536 for US and 76942 and 10022 for USFNA-related procedures. The USFNA codes should be used repeatedly for correct coding of biopsies from multiple sites. Cost (equipment) sharing between specialties is a potential strategy for office-based US incorporation.
CONCLUSION: Based on practice volume, specific CPT coding, and Medicare reimbursements, office-based US equipment and certification costs could be offset in 1 year. SIGNIFICANCE: Office-based US can be readily incorporated with significant benefits to patients. Billing and usage strategies were identified that would improve the economics of providing office-based US.

Entities:  

Mesh:

Year:  2006        PMID: 17141078     DOI: 10.1016/j.otohns.2006.05.004

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancer.

Authors:  S S Yom; A S Garden; G A Staerkel; L E Ginsberg; W H Morrison; E M Sturgis; D I Rosenthal; J N Myers; B S Edeiken-Monroe
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

2.  A lean neck mass clinic model: Adding value to care.

Authors:  Brittny N Tillman; Tiffany A Glazer; Amrita Ray; J Chad Brenner; Matthew E Spector
Journal:  Laryngoscope       Date:  2015-08-08       Impact factor: 3.325

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.